Median Technologies Reports Total Voting Rights and Share Capital as of June 30, 2025
Paris, France – July 7, 2025 – Median Technologies, a leading innovator in artificial intelligence for medical imaging, has formally announced its total number of voting rights and the composition of its share capital as of June 30, 2025. This important disclosure, published by Business Wire French Language News today, provides crucial transparency for the company’s stakeholders.
The announcement, dated July 7, 2025, at 15:45, confirms the latest figures reflecting Median Technologies’ financial and structural standing. Such regular updates are vital for investors, analysts, and regulatory bodies, ensuring an accurate understanding of the company’s issued capital and the associated voting power.
While the specific figures for voting rights and share capital are detailed in the official Business Wire release, this statement underscores Median Technologies’ commitment to corporate governance and transparent communication. By adhering to regulatory requirements for such disclosures, the company reinforces its dedication to building trust and maintaining open dialogue with its shareholder base.
Median Technologies continues to advance its cutting-edge AI solutions for medical imaging, aiming to revolutionize diagnostic and therapeutic pathways in healthcare. This latest corporate update is a testament to the company’s operational maturity and its ongoing efforts to provide clear and timely information to the financial community.
For a comprehensive review of the reported figures, stakeholders are encouraged to consult the official Business Wire French Language News publication.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
Business Wire French Language News published ‘Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 juin 2025’ at 2025-07-07 15:45. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.